AbbVie Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. (ABBV) slid 2.38% to $149.20 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 1.56% to 3,928.86 and Dow Jones Industrial Average falling 1.81% to 33,296.96. This was the stock's second consecutive day of losses. AbbVie Inc. closed $26.71 short of its 52-week high ($175.91), which the company achieved on April 8th.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson (JNJ) fell 1.51% to $169.76 and Pfizer Inc. (PFE) fell 2.34% to $45.00. Trading volume (6.2 M) eclipsed its 50-day average volume of 5.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 18, 2023.
(END) Dow Jones Newswires
January 18, 2023 16:33 ET (21:33 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.